Point-of-Use Mixing of Influenza H5N1 Vaccine and MF59 Adjuvant for Pandemic Vaccination Preparedness: Antibody Responses and Safety. A Phase 1 Clinical Trial.
Open Forum Infect Dis
; 1(3): ofu102, 2014 Dec.
Article
en En
| MEDLINE
| ID: mdl-25734170
Texto completo:
1
Banco de datos:
MEDLINE
Tipo de estudio:
Clinical_trials
Idioma:
En
Año:
2014
Tipo del documento:
Article